Development of abdominal aortic aneurysm is decreased in mice with plasma phospholipid transfer protein deficiency

American Journal of Pathology

Volumn 183, Issue 3, 2013, Pages 975-986

  Deckert, Valérie ^a   Kretz, Benjamin ^a,b   Habbout, Ahmed ^a   Raghay, Kawtar ^a   Labbé, Jérôme ^a   Abello, Nicolas ^b   Desrumaux, Catherine ^a   Gautier, Thomas ^a   Lemaire Ewing, Stéphanie ^a,b   Maquart, Guillaume ^a   Le Guern, Naig ^a   Masson, David ^a,b   Steinmetz, Eric ^a,b   Lagrost, Laurent ^a,b  

^a boulevard Jeanne d'Arc   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; APOENZYME; APOLIPOPROTEIN E; ELASTASE; ELASTIN; MATRIX METALLOPROTEINASE; PHOSPHOLIPID TRANSFER PROTEIN;

ABDOMINAL AORTA ANEURYSM; ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; HETEROZYGOTE; IMMUNOCOMPETENT CELL; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MICROSCOPY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER;

ANGIOTENSIN II; ANIMALS; AORTA; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS E; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; ELASTIN; INFLAMMATION; LIVER; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PANCREATIC ELASTASE; PHOSPHOLIPID TRANSFER PROTEINS;

EID: 84883203565     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.05.018     Document Type: Article

References (53)

1. T. Tzotzas, C. Desrumaux, and L. Lagrost Plasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factor Obes Rev 10 2009 403 411
2. X.C. Jiang, W. Jin, and M. Hussain The impact of phospholipid transfer protein (PLTP) on lipoprotein metabolism Nutr Metab (Lond) 9 2012 75
3. X.C. Jiang, A.R. Tall, S. Qin, M. Lin, M. Schneider, F. Lalanne, V. Deckert, C. Desrumaux, A. Athias, J.L. Witztum, and L. Lagrost Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E J Biol Chem 277 2002 31850 31856
4. C. Desrumaux, V. Deckert, S. Lemaire-Ewing, C. Mossiat, A. Athias, D. Vandroux, L. Dumont, S. Monier, J.P. Pais de Barros, A. Klein, E. De Maistre, D. Blache, A. Beley, C. Marie, P. Garnier, and L. Lagrost Plasma phospholipid transfer protein deficiency in mice is associated with a reduced thrombotic response to acute intravascular oxidative stress Arterioscler Thromb Vasc Biol 30 2010 2452 2457
5. A. Schlitt, J. Liu, D. Yan, M. Mondragon-Escorpizo, A.J. Norin, and X.C. Jiang Anti-inflammatory effects of phospholipid transfer protein (PLTP) deficiency in mice Biochim Biophys Acta 1733 2005 187 191
6. L. Shelly, L. Royer, T. Sand, H. Jensen, and Y. Luo Phospholipid transfer protein deficiency ameliorates diet-induced hypercholesterolemia and inflammation in mice J Lipid Res 49 2008 773 781
7. D.T. Valenta, N. Ogier, G. Bradshaw, A.S. Black, D.J. Bonnet, L. Lagrost, L.K. Curtiss, and C.M. Desrumaux Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression Arterioscler Thromb Vasc Biol 26 2006 1572 1578
8. S. Vuletic, W. Dong, G. Wolfbauer, C. Tang, and J.J. Albers PLTP regulates STAT3 and NFkappaB in differentiated THP1 cells and human monocyte-derived macrophages Biochim Biophys Acta 1813 2011 1917 1924
9. N. Sakalihasan, R. Limet, and O.D. Defawe Abdominal aortic aneurysm Lancet 365 2005 1577 1589
10. J. Golledge, J. Muller, A. Daugherty, and P. Norman Abdominal aortic aneurysm: pathogenesis and implications for management Arterioscler Thromb Vasc Biol 26 2006 2605 2613
11. S.H. Forsdahl, K. Singh, S. Solberg, and B.K. Jacobsen Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromsø Study, 1994-2001 Circulation 119 2009 2202 2208
12. P.K. Shah Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm Circulation 96 1997 2115 2117
13. W.H. Pearce, and V.P. Shively Abdominal aortic aneurysm as a complex multifactorial disease: interactions of polymorphisms of inflammatory genes, features of autoimmunity, and current status of MMPs Ann N Y Acad Sci 1085 2006 117 132
14. T. Freestone, R.J. Turner, A. Coady, D.J. Higman, R.M. Greenhalgh, and J.T. Powell Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm Arterioscler Thromb Vasc Biol 15 1995 1145 1151
15. F. Aziz, and H. Kuivaniemi Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm Ann Vasc Surg 21 2007 392 401
16. E. Petersen, F. Wågberg, and K.A. Angquist Proteolysis of the abdominal aortic aneurysm wall and the association with rupture Eur J Vasc Endovasc Surg 23 2002 153 157
17. G.M. Longo, W. Xiong, T.C. Greiner, Y. Zhao, N. Fiotti, and B.T. Baxter Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms J Clin Invest 110 2002 625 632
18. K.M. Newman, J. Jean-Claude, H. Li, J.V. Scholes, Y. Ogata, H. Nagase, and M.D. Tilson Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall J Vasc Surg 20 1994 814 820
19. K.J. Moore, and I. Tabas Macrophages in the pathogenesis of atherosclerosis Cell 29 145 2011 341 355
20. C.M. Desrumaux, P.A. Mak, W.A. Boisvert, D. Masson, D. Stupack, M. Jauhiainen, C. Ehnholm, and L.K. Curtiss Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells J Lipid Res 44 2003 1453 1461
21. R. Vikstedt, D. Ye, J. Metso, R.B. Hildebrand, T.J. Van Berkel, C. Ehnholm, M. Jauhiainen, and M. Van Eck Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development Arterioscler Thromb Vasc Biol 27 2007 578 586
22. R. Pyo, J.K. Lee, J.M. Shipley, J.A. Curci, D. Mao, S.J. Ziporin, T.L. Ennis, S.D. Shapiro, R.M. Senior, and R.W. Thompson Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms J Clin Invest 105 2000 1641 1649
23. A. Daugherty, M.W. Manning, and L.A. Cassis Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice J Clin Invest 105 2000 1605 1612
24. A. Daugherty, and L.A. Cassis Mouse models of abdominal aortic aneurysms Arterioscler Thromb Vasc Biol 24 2004 429 434
25. X.C. Jiang, C. Bruce, J. Mar, M. Lin, Y. Ji, O.L. Francone, and A.R. Tall Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels J Clin Invest 103 1999 907 914
26. M. Bouly, D. Masson, B. Gross, X.C. Jiang, C. Fievet, G. Castro, A.R. Tall, J.C. Fruchart, B. Staels, L. Lagrost, and G. Luc Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate J Biol Chem 276 2001 25841 25847
27. A.Y. Tu, and J.J. Albers Functional analysis of the transcriptional activity of the mouse phospholipid transfer protein gene Biochem Biophys Res Commun 287 2001 921 926
28. J. Lie, I.M. Lankhuize, B. Gross, T. van Gent, R. van Haperen, L. Scheek, B. Staels, R. de Crom, and A. van Tol Fenofibrate reverses the decline in HDL cholesterol in mice overexpressing human phospholipid transfer protein Biochim Biophys Acta 1738 2005 48 53
29. K. Satoh, P. Nigro, T. Matoba, M.R. O'Dell, Z. Cui, X. Shi, A. Mohan, C. Yan, J. Abe, K.A. Illig, and B.C. Berk Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms Nat Med 15 2009 649 656
30. O. Liu, L. Jia, X. Liu, Y. Wang, X. Wang, Y. Qin, J. Du, and H. Zhang Clopidogrel, a platelet P2Y12 receptor inhibitor, reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression PLoS One 7 2012 e51707
31. A. Daugherty, M.W. Manning, and L.A. Cassis Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis Br J Pharmacol 134 2001 865 870
32. M.W. Manning, L.A. Cassis, J. Huang, S.J. Szilvassy, and A. Daugherty Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease Vasc Med 7 2002 45 54
33. D. Masson, V. Drouineaud, P. Moiroux, T. Gautier, G. Dautin, M. Schneider, J. Fruchart-Najib, M. Jauhiainen, C. Ehnholm, P. Sagot, P. Gambert, C. Jimenez, and L. Lagrost Human seminal plasma displays significant phospholipid transfer activity due to the presence of active phospholipid transfer protein Mol Hum Reprod 9 2003 457 464
34. S. Anidjar, J.L. Salzmann, D. Gentric, P. Lagneau, J.P. Camilleri, and J.B. Michel Elastase-induced experimental aneurysms in rats Circulation 82 1990 973 981
35. V.J. Halpern, G.B. Nackman, R.H. Gandhi, E. Irizarry, J.V. Scholes, W.G. Ramey, and M.D. Tilson The elastase infusion model of experimental aortic aneurysms: synchrony of induction of endogenous proteinases with matrix destruction and inflammatory cell response J Vasc Surg 20 1994 51 60
36. J.S. Lindholt, and G.P. Shi Chronic inflammation, immune response, and infection in abdominal aortic aneurysms Eur J Vasc Endovasc Surg 31 2006 453 463
37. D. Yan, M. Navab, C. Bruce, A.M. Fogelman, and X.C. Jiang PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity J Lipid Res 45 2004 1852 1858
38. F.E. Parodi, D. Mao, T.L. Ennis, M.A. Bartoli, and R.W. Thompson Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-kappaB J Vasc Surg 41 2005 479 489
39. H.A. Uchida, A. Poduri, V. Subramanian, L.A. Cassis, and A. Daugherty Urokinase-type plasminogen activator deficiency in bone marrow-derived cells augments rupture of angiotensin II-induced abdominal aortic aneurysms Arterioscler Thromb Vasc Biol 31 2011 2845 2852
40. C.P. Hans, S.N. Koenig, N. Huang, J. Cheng, S. Beceiro, A. Guggilam, H. Kuivaniemi, S. Partida-Sánchez, and V. Garg Inhibition of Notch1 signaling reduces abdominal aortic aneurysm in mice by attenuating macrophage-mediated inflammation Arterioscler Thromb Vasc Biol 32 2012 3012 3023
41. L.N. Zhang, J. Vincelette, Y. Cheng, U. Mehra, D. Chen, S.K. Anandan, R. Gless, H.K. Webb, and Y.X. Wang Inhibition of soluble epoxide hydrolase attenuated atherosclerosis abdominal aortic aneurysm formation, and dyslipidemia Arterioscler Thromb Vasc Biol 29 2009 1265 1270
42. X.C. Jiang, S. Qin, C. Qiao, K. Kawano, M. Lin, A. Skold, X. Xiao, and A.R. Tall Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency [Erratum appeared in Nat Med 2001, 7:973] Nat Med 7 2001 847 852
43. R. Liu, J. Iqbal, C. Yeang, D.Q. Wang, M.M. Hussain, and X.C. Jiang Phospholipid transfer protein-deficient mice absorb less cholesterol Arterioscler Thromb Vasc Biol 27 2007 2014 2021
44. J.P. Habashi, J.J. Doyle, T.M. Holm, H. Aziz, F. Schoenhoff, D. Bedja, Y. Chen, A.N. Modiri, D.P. Judge, and H.C. Dietz Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism Science 332 2011 361 365
45. V. Tiyerili, C.F. Mueller, U.M. Becher, T. Czech, M. van Eickels, A. Daiber, G. Nickenig, and S. Wassmann Stimulation of the AT2 receptor reduced atherogenesis in ApoE(-/-)/AT1A(-/-) double knock out mice J Mol Cell Cardiol 52 2012 630 637
46. G. Ortiz-Muñoz, X. Houard, J.L. Martín-Ventura, B.Y. Ishida, S. Loyau, P. Rossignol, J.A. Moreno, J.P. Kane, R.J. Chalkley, A.L. Burlingame, J.B. Michel, and O. Meilhac HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property FASEB J 23 2009 3129 3139
47. M. Rizzo, P.A. Krayenbühl, V. Pernice, A. Frasheri, G. Battista Rini, and K. Berneis LDL size and subclasses in patients with abdominal aortic aneurysm Int J Cardiol 134 2009 406 408
48. N. Diehm, F. Dick, T. Schaffner, J. Schmidli, C. Kalka, S. Di Santo, J. Voelzmann, and I. Baumgartner Novel insight into the pathobiology of abdominal aortic aneurysm and potential future treatment concepts Prog Cardiovasc Dis 50 2007 209 217
49. M.C. Cheung, B.G. Brown, E.K. Marino Larsen, A.D. Frutkin, K.D. O'Brien, and J.J. Albers Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease Biochim Biophys Acta 1762 2006 131 137
50. A. Schlitt, C. Bickel, P. Thumma, S. Blankenberg, H.J. Rupprecht, J. Meyer, and X.C. Jiang High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease Arterioscler Thromb Vasc Biol 23 2003 1857 1862
51. H. Yatsuya, K. Tamakoshi, H. Hattori, R. Otsuka, K. Wada, H. Zhang, T. Mabuchi, M. Ishikawa, C. Murata, T. Yoshida, T. Kondo, and H. Toyoshima Serum phospholipid transfer protein mass as a possible protective factor for coronary heart diseases Circ J 68 2004 11 16
52. W. Schgoer, T. Mueller, M. Jauhiainen, A. Wehinger, R. Gander, I. Tancevski, K. Salzmann, P. Eller, A. Ritsch, M. Haltmayer, C. Ehnholm, J.R. Patsch, and B. Foeger Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis Atherosclerosis 196 2008 219 226
53. S. Urbonavicius, G. Urbonaviciene, B. Honoré, E.W. Henneberg, H. Vorum, and J.S. Lindholt Potential circulating biomarkers for abdominal aortic aneurysm expansion and rupture-a systematic review Eur J Vasc Endovasc Surg 36 2008 273 280